Therapeutic Asset Ratings

308 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
GLUCOSE, ANHYDROUS Melanoma	Peter MacCallum Cancer Centre, Australia	N/A	D (28)
ICG-99mTc-nanoscan Melanoma	The Netherlands Cancer Institute	N/A	D (28)
LAVENDER OIL Melanoma	San Gallicano Dermatological Institute IRCCS	N/A	D (28)
Nicotine Melanoma	Institut Cancerologie de l'Ouest	N/A	D (28)
Tisagenlecleucel Melanoma	National Cancer Institute (NCI)		D (28)
Trastuzumab Deruxtecan Melanoma	AstraZeneca		D (28)
avt32-drl_pb Melanoma	Alvotech Swiss AG	P1	NR (0)
Bmab1700 Melanoma	Biocon Biologics UK PLC	P1	NR (0)

Showing 301 to 308 of 308 assets

PreviousPage 13 of 13Next